By Business Wire
Publication Date: 2026-02-18 13:30:00
Yair Heller appoints CEO and co-founder Joseph Mossel to lead strategic growth initiatives as Ibex accelerates its global impact
BOSTON & TEL AVIV, Israel, February 18, 2026–(BUSINESS WIRE)–Ibex Medical Analytics (Ibex), the global leader in clinical-grade AI-powered pathology, today announced continued commercial momentum and expansion of global adoption, as well as a leadership change designed to accelerate the company’s next phase of growth. Effective immediately, Yair Heller, previously Chief Operating Officer, has been appointed Chief Executive Officer and co-founder Joseph Mossel will lead Ibex’s rapidly growing biopharma division and clinical growth initiatives in the US.
“Ibex has been built on a strong foundation and enters 2026 with tremendous momentum and a clear path to scale our platform globally,” said Yair Heller, Chief Executive Officer of Ibex. “As we grow, we will continue to provide pathologists with the most accurate and reliable tools to…
